BioMarin Pharmaceutical Inc. (0HNC.L)
USD 66.73
(-0.75%)
USD 66.73
(-0.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.41 Billion | 2.09 Billion | 1.84 Billion | 1.86 Billion | 1.7 Billion | 1.49 Billion |
| Cost of Revenue | 514.85 Million | 483.66 Million | 470.51 Million | 524.27 Million | 359.46 Million | 315.26 Million |
| Gross Profit | 1.9 Billion | 1.61 Billion | 1.37 Billion | 1.33 Billion | 1.34 Billion | 1.17 Billion |
| Operating Expenses | 1.74 Billion | 1.57 Billion | 1.45 Billion | 1.43 Billion | 1.47 Billion | 1.34 Billion |
| Selling, General and Administrative Expenses | 937.3 Million | 854 Million | 759.37 Million | 737.66 Million | 680.92 Million | 604.35 Million |
| Research and Development Expenses | 746.77 Million | 649.6 Million | 628.79 Million | 628.11 Million | 715 Million | 696.32 Million |
| Other Expenses | - | 67.19 Million | 69.93 Million | 66.65 Million | 74.1 Million | 2.2 Million |
| Cost and Expenses | 2.26 Billion | 2.05 Billion | 1.92 Billion | 1.95 Billion | 1.82 Billion | 1.66 Billion |
| Operating Income | 194.44 Million | 57.54 Million | -60.01 Million | -96.26 Million | -125.45 Million | -123.52 Million |
| Interest Expense | 17.33 Million | 15.97 Million | 15.33 Million | 29.3 Million | 23.46 Million | 43.66 Million |
| Income Tax Expense | 20.91 Million | 8.01 Million | -11.27 Million | -901.42 Million | -70.96 Million | -65.49 Million |
| Earnings before Tax | 188.56 Million | 149.57 Million | -75.35 Million | -42.32 Million | -94.81 Million | -142.7 Million |
| Net Income | 167.64 Million | 141.56 Million | -64.08 Million | 854.02 Million | -23.84 Million | -77.21 Million |
| Earnings Per Share Basic | 0.89 | 0.76 | -0.35 | 4.75 | -0.13 | -0.44 |
| Earnings Per Share Diluted | 0.87 | 0.75 | -0.35 | 4.53 | -0.13 | -0.44 |
| Weighted Average Shares Outstanding | 187.83 Million | 185.26 Million | 182.85 Million | 180.8 Million | 179.03 Million | 177.06 Million |
| Weighted Average Shares Outstanding (Diluted) | 191.59 Million | 188.96 Million | 182.85 Million | 191.67 Million | 179.03 Million | 177.26 Million |
| Gross Margin | 0.79 | 0.77 | 0.75 | 0.72 | 0.79 | 0.79 |
| EBIT Margin | 0.13 | 0.08 | 0.03 | -0.00 | -0.01 | -0.07 |
| Profit Margin | 0.07 | 0.07 | -0.03 | 0.46 | -0.01 | -0.05 |
| EBITDA | 310.28 Million | 267.51 Million | 48.02 Million | -5.85 Million | 33.94 Million | -3.54 Million |
| Earnings Before Tax Margin | 0.08 | 0.03 | -0.03 | -0.05 | -0.07 | -0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 733.86 Billion | 708.65 Million | 648.83 Million | 2.41 Billion | 646.2 Million | 585.96 Million |
| Cost of Revenue | 188.45 Billion | 144.75 Million | 139.47 Million | 577.06 Million | 135.47 Million | 140.42 Million |
| Gross Profit | 545.41 Billion | 563.9 Million | 509.35 Million | 1.84 Billion | 510.72 Million | 445.53 Million |
| Operating Expenses | 443.39 Billion | 460.44 Million | 427.49 Million | 1.68 Billion | 496.51 Million | 422.7 Million |
| Selling, General and Administrative Expenses | 253.48 Billion | 276.65 Million | 222.5 Million | - | 275.02 Million | 231.39 Million |
| Research and Development Expenses | 184.9 Billion | 183.78 Million | 204.98 Million | - | 206.25 Million | 191.31 Million |
| Other Expenses | 5 Billion | -4.52 Million | 204.98 Million | -10.53 Million | -15.23 Million | 4.04 Million |
| Cost and Expenses | 631.84 Billion | 605.19 Million | 566.97 Million | 2.26 Billion | 631.98 Million | 563.13 Million |
| Operating Income | 113.89 Billion | 103.45 Million | 81.86 Million | 157.59 Million | 14.21 Million | 22.83 Million |
| Interest Expense | -2.96 Billion | 3.57 Million | 3.54 Million | 17.33 Million | 6.09 Million | 3.77 Million |
| Income Tax Expense | 28.36 Billion | 24.96 Million | 16.88 Million | 20.91 Million | -1.04 Million | 1.29 Million |
| Earnings before Tax | 134.44 Billion | 132.13 Million | 105.54 Million | 188.56 Million | 19.32 Million | 41.66 Million |
| Net Income | 106.08 Billion | 107.17 Million | 88.66 Million | 167.64 Million | 20.37 Million | 40.37 Million |
| Earnings Per Share Basic | 557.06 | 0.56 | 0.47 | - | 0.11 | 0.21 |
| Earnings Per Share Diluted | 538.08 | 0.55 | 0.44 | - | 0.11 | 0.21 |
| Weighted Average Shares Outstanding | 190.42 Million | 190.11 Million | 188.86 Million | 187.83 Million | 188.47 Million | 188.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 197.14 Million | 200.5 Million | 199.26 Million | 191.59 Million | 191.83 Million | 191.17 Million |
| Gross Margin | 0.74 | 0.80 | 0.79 | 0.76 | 0.79 | 0.76 |
| EBIT Margin | 0.16 | 0.18 | 0.17 | - | 0.06 | 0.08 |
| Profit Margin | 0.14 | 0.15 | 0.14 | 0.07 | 0.03 | 0.07 |
| EBITDA | 113.89 Billion | 129.92 Million | 109.21 Million | - | 41.08 Million | 48.51 Million |
| Earnings Before Tax Margin | 0.16 | 0.15 | 0.13 | 0.07 | 0.02 | 0.04 |
FMCCL
7202
CDMO
AEG
TPHQ
BLMH